Peter L. Collins
#116,154
Most Influential Person Now
Peter L. Collins's AcademicInfluence.com Rankings
Peter L. Collinsbiology Degrees
Biology
#6739
World Rank
#9522
Historical Rank
Virology
#141
World Rank
#146
Historical Rank
Microbiology
#309
World Rank
#355
Historical Rank
Download Badge
Biology
Peter L. Collins's Degrees
- PhD Microbiology University of California, San Francisco
- Bachelors Biology Stanford University
Similar Degrees You Can Earn
Why Is Peter L. Collins Influential?
(Suggest an Edit or Addition)Peter L. Collins's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Respiratory Syncytial Virus Infection of Human Airway Epithelial Cells Is Polarized, Specific to Ciliated Cells, and without Obvious Cytopathology (2002) (519)
- The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins. (1987) (513)
- Viral and Host Factors in Human Respiratory Syncytial Virus Pathogenesis (2007) (457)
- Respiratory syncytial virus and metapneumovirus (2007) (449)
- Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development. (1995) (443)
- Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. (2004) (421)
- Suppression of the Induction of Alpha, Beta, and Gamma Interferons by the NS1 and NS2 Proteins of Human Respiratory Syncytial Virus in Human Epithelial Cells and Macrophages (2004) (398)
- Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years. (2011) (395)
- Taxonomy of the order Mononegavirales: update 2016 (2016) (389)
- Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. (2004) (372)
- Normal and Cystic Fibrosis Airway Surface Liquid Homeostasis (2005) (328)
- Severe Acute Respiratory Syndrome Coronavirus Infection of Human Ciliated Airway Epithelia: Role of Ciliated Cells in Viral Spread in the Conducting Airways of the Lungs (2005) (318)
- Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. (1986) (308)
- Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein. (1985) (307)
- Glycosaminoglycan Sulfation Requirements for Respiratory Syncytial Virus Infection (2000) (294)
- Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus. (1996) (284)
- Effects of Nonstructural Proteins NS1 and NS2 of Human Respiratory Syncytial Virus on Interferon Regulatory Factor 3, NF-κB, and Proinflammatory Cytokines (2005) (278)
- Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS (2004) (275)
- Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants. (2005) (271)
- Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity (1987) (268)
- Infection of Ciliated Cells by Human Parainfluenza Virus Type 3 in an In Vitro Model of Human Airway Epithelium (2005) (266)
- Recombinant Respiratory Syncytial Virus Bearing a Deletion of either the NS2 or SH Gene Is Attenuated in Chimpanzees (1999) (250)
- Suppression of the Induction of Alpha, Beta, and Lambda Interferons by the NS1 and NS2 Proteins of Human Respiratory Syncytial Virus in Human Epithelial Cells and Macrophages (2004) (250)
- Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse (1997) (245)
- Role of the M2-1 Transcription Antitermination Protein of Respiratory Syncytial Virus in Sequential Transcription (1999) (240)
- Genetic diversity between human metapneumovirus subgroups. (2003) (239)
- Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection. (2000) (239)
- Taxonomy of the order Mononegavirales: update 2017 (2017) (236)
- The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription. (1999) (235)
- Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo. (2001) (233)
- Nucleotide sequence of the gene encoding the fusion (F) glycoprotein of human respiratory syncytial virus. (1984) (221)
- RNA replication by respiratory syncytial virus (RSV) is directed by the N, P, and L proteins; transcription also occurs under these conditions but requires RSV superinfection for efficient synthesis of full-length mRNA (1995) (205)
- Recombinant Respiratory Syncytial Virus That Does Not Express the NS1 or M2-2 Protein Is Highly Attenuated and Immunogenic in Chimpanzees (2000) (203)
- Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived (1991) (201)
- Recombinant Human Metapneumovirus Lacking the Small Hydrophobic SH and/or Attachment G Glycoprotein: Deletion of G Yields a Promising Vaccine Candidate (2004) (200)
- Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease. (2013) (194)
- CFTR Delivery to 25% of Surface Epithelial Cells Restores Normal Rates of Mucus Transport to Human Cystic Fibrosis Airway Epithelium (2009) (183)
- ICTV Virus Taxonomy Profile: Pneumoviridae. (2017) (178)
- The Two Major Human Metapneumovirus Genetic Lineages Are Highly Related Antigenically, and the Fusion (F) Protein Is a Major Contributor to This Antigenic Relatedness (2004) (176)
- Newcastle disease virus stimulates the cellular accumulation of stress (heat shock) mRNAs and proteins (1982) (164)
- Successful Topical Respiratory Tract Immunization of Primates against Ebola Virus (2007) (161)
- Taxonomy of the order Mononegavirales: update 2018 (2018) (155)
- The Secreted Form of Respiratory Syncytial Virus G Glycoprotein Helps the Virus Evade Antibody-Mediated Restriction of Replication by Acting as an Antigen Decoy and through Effects on Fc Receptor-Bearing Leukocytes (2008) (151)
- Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia--RSV recombinants or RSV. (1992) (148)
- Infection of Nonhuman Primates with Recombinant Human Metapneumovirus Lacking the SH, G, or M2-2 Protein Categorizes Each as a Nonessential Accessory Protein and Identifies Vaccine Candidates (2005) (146)
- A Chimeric A2 Strain of Respiratory Syncytial Virus (RSV) with the Fusion Protein of RSV Strain Line 19 Exhibits Enhanced Viral Load, Mucus, and Airway Dysfunction (2009) (146)
- The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines. (2007) (143)
- The fusion glycoproteins of human respiratory syncytial virus of subgroups A and B: sequence conservation provides a structural basis for antigenic relatedness. (1988) (143)
- Nucleotide sequences for the gene junctions of human respiratory syncytial virus reveal distinctive features of intergenic structure and gene order. (1986) (143)
- Identification of a tenth mRNA of respiratory syncytial virus and assignment of polypeptides to the 10 viral genes (1984) (138)
- Respiratory Syncytial Virus Infection Sensitizes Cells to Apoptosis Mediated by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (2003) (137)
- Rescue of synthetic analogs of respiratory syncytial virus genomic RNA and effect of truncations and mutations on the expression of a foreign reporter gene. (1991) (137)
- Post-translational processing and oligomerization of the fusion glycoprotein of human respiratory syncytial virus. (1991) (135)
- Identification of the Respiratory Syncytial Virus Proteins Required for Formation and Passage of Helper-Dependent Infectious Particles (1998) (134)
- An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines. (1994) (134)
- Characterization of the 10 proteins of human respiratory syncytial virus: identification of a fourth envelope-associated protein. (1985) (132)
- Recovery of human metapneumovirus from cDNA: optimization of growth in vitro and expression of additional genes. (2004) (127)
- Respiratory syncytial virus with the fusion protein as its only viral glycoprotein is less dependent on cellular glycosaminoglycans for attachment than complete virus. (2002) (126)
- Fusion glycoprotein of human parainfluenza virus type 3: nucleotide sequence of the gene, direct identification of the cleavage-activation site, and comparison with other paramyxoviruses. (1986) (125)
- Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens (2007) (124)
- Altered Growth Characteristics of Recombinant Respiratory Syncytial Viruses Which Do Not Produce NS2 Protein (1999) (123)
- Live-attenuated respiratory syncytial virus vaccines. (2013) (123)
- Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunity (1987) (121)
- Recombinant Newcastle Disease Virus Expressing a Foreign Viral Antigen Is Attenuated and Highly Immunogenic in Primates (2005) (118)
- RSV604, a Novel Inhibitor of Respiratory Syncytial Virus Replication (2007) (117)
- Individual contributions of the human metapneumovirus F, G, and SH surface glycoproteins to the induction of neutralizing antibodies and protective immunity. (2006) (117)
- Effects of mutations in the gene-start and gene-end sequence motifs on transcription of monocistronic and dicistronic minigenomes of respiratory syncytial virus (1996) (114)
- Nonstructural Proteins 1 and 2 of Respiratory Syncytial Virus Suppress Maturation of Human Dendritic Cells (2008) (114)
- Increased expression of the N protein of respiratory syncytial virus stimulates minigenome replication but does not alter the balance between the synthesis of mRNA and antigenome. (1997) (113)
- Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus (1995) (113)
- Recovery of infectious human parainfluenza virus type 3 from cDNA. (1997) (113)
- Sequence analysis of the polymerase L gene of human respiratory syncytial virus and predicted phylogeny of nonsegmented negative-strand viruses. (1991) (112)
- Alpha and Lambda Interferon Together Mediate Suppression of CD4 T Cells Induced by Respiratory Syncytial Virus (2006) (112)
- Transcriptional mapping of human respiratory syncytial virus (1984) (112)
- Respiratory Syncytial Virus Interferon Antagonist NS1 Protein Suppresses and Skews the Human T Lymphocyte Response (2011) (111)
- RhoA Signaling Is Required for Respiratory Syncytial Virus-Induced Syncytium Formation and Filamentous Virion Morphology (2005) (111)
- Nonsegmented Negative-Strand Viruses as Vaccine Vectors (2006) (111)
- The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin. (2005) (111)
- Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial viruses. (1988) (107)
- The NS1 Protein of Human Respiratory Syncytial Virus Is a Potent Inhibitor of Minigenome Transcription and RNA Replication (1998) (107)
- Analysis of the gene start and gene end signals of human respiratory syncytial virus: quasi-templated initiation at position 1 of the encoded mRNA (1997) (103)
- Attenuation of human respiratory syncytial virus by genome-scale codon-pair deoptimization (2014) (102)
- Cloning and nucleotide sequence of Newcastle disease virus hemagglutinin-neuraminidase mRNA: identification of a putative sialic acid binding site. (1987) (102)
- Recurrent rhinovirus infections in a child with inherited MDA5 deficiency (2017) (101)
- cDNA cloning and transcriptional mapping of nine polyadenylylated RNAs encoded by the genome of human respiratory syncytial virus. (1983) (101)
- A Single Intranasal Inoculation with a Paramyxovirus-Vectored Vaccine Protects Guinea Pigs against a Lethal-Dose Ebola Virus Challenge (2006) (101)
- Oligomerization and post-translational processing of glycoprotein G of human respiratory syncytial virus: altered O-glycosylation in the presence of brefeldin A. (1992) (100)
- Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses (1988) (100)
- Mutations in the C, D, and V open reading frames of human parainfluenza virus type 3 attenuate replication in rodents and primates. (1999) (100)
- Conserved epitopes on the hemagglutinin-neuraminidase proteins of human and bovine parainfluenza type 3 viruses: nucleotide sequence analysis of variants selected with monoclonal antibodies (1986) (100)
- A comparison in chimpanzees of the immunogenicity and efficacy of live attenuated respiratory syncytial virus (RSV) temperature-sensitive mutant vaccines and vaccinia virus recombinants that express the surface glycoproteins of RSV. (1993) (100)
- The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans. (2006) (99)
- Immunization of Primates with a Newcastle Disease Virus-Vectored Vaccine via the Respiratory Tract Induces a High Titer of Serum Neutralizing Antibodies against Highly Pathogenic Avian Influenza Virus (2007) (99)
- Recombinant Bovine/Human Parainfluenza Virus Type 3 (B/HPIV3) Expressing the Respiratory Syncytial Virus (RSV) G and F Proteins Can Be Used To Achieve Simultaneous Mucosal Immunization against RSV and HPIV3 (2001) (99)
- The 1A protein of respiratory syncytial virus is an integral membrane protein present as multiple, structurally distinct species (1989) (98)
- A gene deletion that up-regulates viral gene expression yields an attenuated RSV vaccine with improved antibody responses in children (2015) (98)
- Deletion of M2 Gene Open Reading Frames 1 and 2 of Human Metapneumovirus: Effects on RNA Synthesis, Attenuation, and Immunogenicity (2005) (97)
- Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8+ T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antibodies (1992) (97)
- The Molecular Biology of Human Respiratory Syncytial Virus (RSV) of the Genus Pneumovirus (1991) (94)
- Gene overlap and site-specific attenuation of transcription of the viral polymerase L gene of human respiratory syncytial virus. (1987) (94)
- Genetic Recombination during Coinfection of Two Mutants of Human Respiratory Syncytial Virus (2003) (92)
- Addition of a Missense Mutation Present in the L Gene of Respiratory Syncytial Virus (RSV) cpts530/1030 to RSV Vaccine Candidate cpts248/404 Increases Its Attenuation and Temperature Sensitivity (1999) (92)
- The Respiratory Syncytial Virus Fusion Protein and Neutrophils Mediate the Airway Mucin Response to Pathogenic Respiratory Syncytial Virus Infection (2013) (91)
- Respiratory Syncytial Virus (RSV) G Glycoprotein Is Not Necessary for Vaccine-Enhanced Disease Induced by Immunization with Formalin-Inactivated RSV (2004) (91)
- Recombinant Respiratory Syncytial Virus (RSV) Bearing a Set of Mutations from Cold-Passaged RSV Is Attenuated in Chimpanzees (1998) (91)
- Cytolytic T-lymphocyte responses to respiratory syncytial virus: effector cell phenotype and target proteins (1990) (91)
- Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics. (1999) (91)
- Recovery of infectious respiratory syncytial virus expressing an additional, foreign gene (1996) (89)
- New generation live vaccines against human respiratory syncytial virus designed by reverse genetics. (2005) (89)
- Progress in the development of human parainfluenza virus vaccines (2011) (89)
- Newcastle Disease Virus-Vectored Vaccines Expressing the Hemagglutinin or Neuraminidase Protein of H5N1 Highly Pathogenic Avian Influenza Virus Protect against Virus Challenge in Monkeys (2009) (87)
- Membrane orientation and oligomerization of the small hydrophobic protein of human respiratory syncytial virus. (1993) (87)
- Mucosal Immunization of Rhesus Monkeys against Respiratory Syncytial Virus Subgroups A and B and Human Parainfluenza Virus Type 3 by Using a Live cDNA-Derived Vaccine Based on a Host Range-Attenuated Bovine Parainfluenza Virus Type 3 Vector Backbone (2002) (86)
- The 1B (NS2), 1C (NS1) and N proteins of human respiratory syncytial virus (RSV) of antigenic subgroups A and B: sequence conservation and divergence within RSV genomic RNA. (1989) (86)
- Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse genetics. (2002) (86)
- Bovine Parainfluenza Virus Type 3 (BPIV3) Fusion and Hemagglutinin-Neuraminidase Glycoproteins Make an Important Contribution to the Restricted Replication of BPIV3 in Primates (2000) (85)
- RSV-encoded NS2 promotes epithelial cell shedding and distal airway obstruction. (2014) (85)
- Nucleotide sequences of the 3' leader and 5' trailer regions of human respiratory syncytial virus genomic RNA. (1991) (85)
- Generation by Reverse Genetics of an Effective, Stable, Live-Attenuated Newcastle Disease Virus Vaccine Based on a Currently Circulating, Highly Virulent Indonesian Strain (2012) (85)
- RNA replication by a respiratory syncytial virus RNA analog does not obey the rule of six and retains a nonviral trinucleotide extension at the leader end (1996) (84)
- Chimeric Bovine Respiratory Syncytial Virus with Glycoprotein Gene Substitutions from Human Respiratory Syncytial Virus (HRSV): Effects on Host Range and Evaluation as a Live-Attenuated HRSV Vaccine (2000) (84)
- Human parainfluenza virus type 3: messenger RNAs, polypeptide coding assignments, intergenic sequences, and genetic map (1986) (84)
- Virus Replication in Engineered Human Cells That Do Not Respond to Interferons (2003) (84)
- Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response (2010) (83)
- Immunization of Chickens with Newcastle Disease Virus Expressing H5 Hemagglutinin Protects against Highly Pathogenic H5N1 Avian Influenza Viruses (2009) (83)
- Coding assignments of the five smaller mRNAs of Newcastle disease virus (1982) (82)
- Identification of Mutations Contributing to the Temperature-Sensitive, Cold-Adapted, and Attenuation Phenotypes of the Live-Attenuated Cold-Passage 45 (cp45) Human Parainfluenza Virus 3 Candidate Vaccine (1999) (82)
- Contributions of the Avian Influenza Virus HA, NA, and M2 Surface Proteins to the Induction of Neutralizing Antibodies and Protective Immunity (2009) (79)
- Evaluation of the Newcastle Disease Virus F and HN Proteins in Protective Immunity by Using a Recombinant Avian Paramyxovirus Type 3 Vector in Chickens (2011) (79)
- Model for Polymerase Access to the Overlapped L Gene of Respiratory Syncytial Virus (1999) (78)
- Minimum protein requirements for transcription and RNA replication of a minigenome of human parainfluenza virus type 3 and evaluation of the rule of six. (1997) (78)
- Three Amino Acid Substitutions in the L Protein of the Human Parainfluenza Virus Type 3 cp45 Live Attenuated Vaccine Candidate Contribute to Its Temperature-Sensitive and Attenuation Phenotypes (1998) (77)
- The Central Conserved Cystine Noose of the Attachment G Protein of Human Respiratory Syncytial Virus Is Not Required for Efficient Viral Infection In Vitro or In Vivo (2002) (75)
- Interaction between the respiratory syncytial virus G glycoprotein cytoplasmic domain and the matrix protein. (2005) (75)
- Mapping the Transcription and Replication Promoters of Respiratory Syncytial Virus (2002) (74)
- Rapid human metapneumovirus microneutralization assay based on green fluorescent protein expression. (2005) (74)
- Respiratory syncytial virus: reverse genetics and vaccine strategies. (2002) (72)
- Immunogenicity of recombinant adenovirus-respiratory syncytial virus vaccines with adenovirus types 4, 5, and 7 vectors in dogs and a chimpanzee. (1992) (71)
- Expression of biologically active and antigenically authentic parainfluenza type 3 virus hemagglutinin-neuraminidase glycoprotein by a recombinant baculovirus. (1987) (71)
- Newcastle disease virus as a vaccine vector for humans. (2008) (71)
- Complete Genome Sequences of Newcastle Disease Virus Strains Circulating in Chicken Populations of Indonesia (2012) (70)
- Evaluation in chimpanzees of vaccinia virus recombinants that express the surface glycoproteins of human respiratory syncytial virus. (1990) (70)
- The structurally diverse intergenic regions of respiratory syncytial virus do not modulate sequential transcription by a dicistronic minigenome (1996) (70)
- Serious respiratory tract disease caused by respiratory syncytial virus: prospects for improved therapy and effective immunization. (1992) (70)
- Expression of the major glycoprotein G of human respiratory syncytial virus from recombinant vaccinia virus vectors. (1986) (69)
- Granulocyte-Macrophage Colony-Stimulating Factor Expressed by Recombinant Respiratory Syncytial Virus Attenuates Viral Replication and Increases the Level of Pulmonary Antigen-Presenting Cells (2001) (69)
- A single nucleotide substitution in the transcription start signal of the M2 gene of respiratory syncytial virus vaccine candidate cpts248/404 is the major determinant of the temperature-sensitive and attenuation phenotypes. (1998) (69)
- Interferon gamma expressed by a recombinant respiratory syncytial virus attenuates virus replication in mice without compromising immunogenicity. (1999) (69)
- Transcriptional map for Newcastle disease virus (1980) (68)
- The two open reading frames of the 22K mRNA of human respiratory syncytial virus: sequence comparison of antigenic subgroups A and B and expression in vitro. (1990) (68)
- Respiratory Syncytial Virus Modified by Deletions of the NS2 Gene and Amino Acid S1313 of the L Polymerase Protein Is a Temperature-Sensitive, Live-Attenuated Vaccine Candidate That Is Phenotypically Stable at Physiological Temperature (2012) (67)
- The envelope-associated 22K protein of human respiratory syncytial virus: nucleotide sequence of the mRNA and a related polytranscript (1985) (67)
- RhoA is activated during respiratory syncytial virus infection. (2001) (66)
- Pathogenesis of acute respiratory illness caused by human parainfluenza viruses. (2012) (66)
- The small hydrophobic protein of human respiratory syncytial virus: comparison between antigenic subgroups A and B. (1990) (65)
- Recovery of a Fully Viable Chimeric Human Parainfluenza Virus (PIV) Type 3 in Which the Hemagglutinin-Neuraminidase and Fusion Glycoproteins Have Been Replaced by Those of PIV Type 1 (1998) (63)
- Aerosolized Ebola vaccine protects primates and elicits lung-resident T cell responses. (2015) (62)
- Infection and maturation of monocyte-derived human dendritic cells by human respiratory syncytial virus, human metapneumovirus, and human parainfluenza virus type 3. (2009) (62)
- Sequence analysis of the P and C protein genes of human parainfluenza virus type 3: patterns of amino acid sequence homology among paramyxovirus proteins. (1986) (62)
- Chimeric Recombinant Human Metapneumoviruses with the Nucleoprotein or Phosphoprotein Open Reading Frame Replaced by That of Avian Metapneumovirus Exhibit Improved Growth In Vitro and Attenuation In Vivo (2005) (61)
- Chimeric human parainfluenza virus bearing the Ebola virus glycoprotein as the sole surface protein is immunogenic and highly protective against Ebola virus challenge. (2009) (61)
- Newcastle Disease Virus Fusion Protein Is the Major Contributor to Protective Immunity of Genotype-Matched Vaccine (2013) (60)
- Soluble Respiratory Syncytial Virus Fusion Protein in the Fully Cleaved, Pretriggered State Is Triggered by Exposure to Low-Molarity Buffer (2011) (60)
- Cholesterol-Rich Microdomains as Docking Platforms for Respiratory Syncytial Virus in Normal Human Bronchial Epithelial Cells (2011) (59)
- Nucleotide sequence analysis of the respiratory syncytial virus subgroup A cold-passaged (cp) temperature sensitive (ts) cpts-248/404 live attenuated virus vaccine candidate. (1996) (59)
- Human Parainfluenza Virus Type 3 (PIV3) Expressing the Hemagglutinin Protein of Measles Virus Provides a Potential Method for Immunization against Measles Virus and PIV3 in Early Infancy (2000) (59)
- Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate (2015) (59)
- The temperature-sensitive (ts) phenotype of a cold-passaged (cp) live attenuated respiratory syncytial virus vaccine candidate, designated cpts530, results from a single amino acid substitution in the L protein (1997) (59)
- Complete genome sequence of avian paramyxovirus type 3 reveals an unusually long trailer region. (2008) (59)
- Functional Analysis of the Genomic and Antigenomic Promoters of Human Respiratory Syncytial Virus (2000) (58)
- The 1A protein gene of human respiratory syncytial virus: nucleotide sequence of the mRNA and a related polycistronic transcript. (1985) (58)
- Responses against a Subdominant CD8+ T Cell Epitope Protect against Immunopathology Caused by a Dominant Epitope (2010) (57)
- Mutations in the 5′ Trailer Region of a Respiratory Syncytial Virus Minigenome Which Limit RNA Replication to One Step (2000) (57)
- Correct sequence for the major nucleocapsid protein mRNA of respiratory syncytial virus. (1985) (57)
- Interleukin 18 Coexpression during Respiratory Syncytial Virus Infection Results in Enhanced Disease Mediated by Natural Killer Cells (2010) (56)
- Transcription and translation of Newcastle disease virus mRNA's in vitro (1978) (55)
- Sendai virus, a murine parainfluenza virus type 1, replicates to a level similar to human PIV1 in the upper and lower respiratory tract of African green monkeys and chimpanzees. (2002) (55)
- Roles of the respiratory syncytial virus trailer region: effects of mutations on genome production and stress granule formation. (2010) (55)
- Animal Model of Respiratory Syncytial Virus: CD8+ T Cells Cause a Cytokine Storm That Is Chemically Tractable by Sphingosine-1-Phosphate 1 Receptor Agonist Therapy (2014) (54)
- Immunization of cattle with recombinant Newcastle disease virus expressing bovine herpesvirus-1 (BHV-1) glycoprotein D induces mucosal and serum antibody responses and provides partial protection against BHV-1 (2010) (54)
- The Human Respiratory Syncytial Virus Nonstructural Protein 1 Regulates Type I and Type II Interferon Pathways* (2012) (54)
- Evaluation of the replication and immunogenicity of recombinant human parainfluenza virus type 3 vectors expressing up to three foreign glycoproteins. (2002) (54)
- The Secreted G Protein of Human Respiratory Syncytial Virus Antagonizes Antibody-Mediated Restriction of Replication Involving Macrophages and Complement (2012) (54)
- The Genome Length of Human Parainfluenza Virus Type 2 Follows the Rule of Six, and Recombinant Viruses Recovered from Non-Polyhexameric-Length Antigenomic cDNAs Contain a Biased Distribution of Correcting Mutations (2003) (53)
- Modification of the Trypsin-Dependent Cleavage Activation Site of the Human Metapneumovirus Fusion Protein To Be Trypsin Independent Does Not Increase Replication or Spread in Rodents or Nonhuman Primates (2006) (53)
- Sequence Analysis of the Washington/1964 Strain of Human Parainfluenza Virus Type 1 (HPIV1) and Recovery and Characterization of Wild-Type Recombinant HPIV1 Produced by Reverse Genetics (2004) (53)
- Mucosal parainfluenza virus-vectored vaccine against Ebola virus replicates in the respiratory tract of vector-immune monkeys and is immunogenic. (2010) (52)
- Replacement of the F and G Proteins of Respiratory Syncytial Virus (RSV) Subgroup A with Those of Subgroup B Generates Chimeric Live Attenuated RSV Subgroup B Vaccine Candidates (1999) (52)
- Increased Genetic and Phenotypic Stability of a Promising Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate by Reverse Genetics (2012) (51)
- Recombinant Respiratory Syncytial Virus with the G and F Genes Shifted to the Promoter-Proximal Positions (2002) (51)
- A cold-passaged, attenuated strain of human respiratory syncytial virus contains mutations in the F and L genes. (1995) (50)
- Roles of the Fusion and Hemagglutinin-Neuraminidase Proteins in Replication, Tropism, and Pathogenicity of Avian Paramyxoviruses (2011) (50)
- Rescue of synthetic analogs of genomic RNA and replicative-intermediate RNA of human parainfluenza virus type 3 (1993) (50)
- Phylogenetic and Pathotypic Characterization of Newcastle Disease Viruses Circulating in West Africa and Efficacy of a Current Vaccine (2012) (49)
- Processing, surface expression, and immunogenicity of carboxy-terminally truncated mutants of G protein of human respiratory syncytial virus (1989) (49)
- Identification of Internal Sequences in the 3′ Leader Region of Human Respiratory Syncytial Virus That Enhance Transcription and Confer Replication Processivity (2005) (49)
- Evaluation of the Contributions of Individual Viral Genes to Newcastle Disease Virus Virulence and Pathogenesis (2014) (48)
- Complete genome sequences of avian paramyxovirus type 8 strains goose/Delaware/1053/76 and pintail/Wakuya/20/78. (2009) (48)
- Actin-Related Protein 2 (ARP2) and Virus-Induced Filopodia Facilitate Human Respiratory Syncytial Virus Spread (2016) (47)
- The C Proteins of Human Parainfluenza Virus Type 1 Limit Double-Stranded RNA Accumulation That Would Otherwise Trigger Activation of MDA5 and Protein Kinase R (2010) (47)
- Molecular characterization and complete genome sequence of avian paramyxovirus type 4 prototype strain duck/Hong Kong/D3/75 (2008) (47)
- Immunization with vaccinia virus recombinants that express the surface glycoproteins of human parainfluenza virus type 3 (PIV3) protects patas monkeys against PIV3 infection (1988) (46)
- p38 and OGT Sequestration into Viral Inclusion Bodies in Cells Infected with Human Respiratory Syncytial Virus Suppresses MK2 Activities and Stress Granule Assembly (2012) (46)
- Generation of a parainfluenza virus type 1 vaccine candidate by replacing the HN and F glycoproteins of the live-attenuated PIV3 cp45 vaccine virus with their PIV1 counterparts. (1999) (44)
- The two amino acid substitutions in the L protein of cpts530/1009, a live-attenuated respiratory syncytial virus candidate vaccine, are independent temperature-sensitive and attenuation mutations. (1999) (44)
- Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in Children (2018) (44)
- Replication, Neurotropism, and Pathogenicity of Avian Paramyxovirus Serotypes 1–9 in Chickens and Ducks (2012) (44)
- Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young children (2011) (44)
- Complete sequence of the genome of avian paramyxovirus type 2 (strain Yucaipa) and comparison with other paramyxoviruses. (2008) (43)
- Frequent Frameshift and Point Mutations in the SH Gene of Human Metapneumovirus Passaged In Vitro (2007) (43)
- Gene shuffling-generated and natural variants of the tomato resistance gene Cf-9 exhibit different auto-necrosis-inducing activities in Nicotiana species. (2004) (43)
- A Recombinant Human Parainfluenza Virus Type 3 (PIV3) in Which the Nucleocapsid N Protein Has Been Replaced by That of Bovine PIV3 Is Attenuated in Primates (2000) (43)
- Generation of Recombinant Human Parainfluenza Virus Type 1 Vaccine Candidates by Importation of Temperature-Sensitive and Attenuating Mutations from Heterologous Paramyxoviruses (2004) (42)
- Low CCR7-Mediated Migration of Human Monocyte Derived Dendritic Cells in Response to Human Respiratory Syncytial Virus and Human Metapneumovirus (2011) (42)
- The NS2 Protein of Human Respiratory Syncytial Virus Suppresses the Cytotoxic T-Cell Response as a Consequence of Suppressing the Type I Interferon Response (2006) (42)
- Complete Genome Sequence of Avian Paramyxovirus (APMV) Serotype 5 Completes the Analysis of Nine APMV Serotypes and Reveals the Longest APMV Genome (2010) (42)
- A live attenuated recombinant chimeric parainfluenza virus (PIV) candidate vaccine containing the hemagglutinin-neuraminidase and fusion glycoproteins of PIV1 and the remaining proteins from PIV3 induces resistance to PIV1 even in animals immune to PIV3. (2000) (42)
- Complete sequence of the genome of avian paramyxovirus type 9 and comparison with other paramyxoviruses. (2009) (42)
- Evaluation in non-human primates of the safety, immunogenicity and efficacy of recombinant vaccinia viruses expressing the F or G glycoprotein of respiratory syncytial virus. (1988) (42)
- Synergistic effects of gene-end signal mutations and the M2-1 protein on transcription termination by respiratory syncytial virus. (2001) (41)
- Comparison of differing cytopathic effects in human airway epithelium of parainfluenza virus 5 (W3A), parainfluenza virus type 3, and respiratory syncytial virus. (2011) (41)
- Replacement of the Ectodomains of the Hemagglutinin-Neuraminidase and Fusion Glycoproteins of Recombinant Parainfluenza Virus Type 3 (PIV3) with Their Counterparts from PIV2 Yields Attenuated PIV2 Vaccine Candidates (2000) (41)
- Differential Responses by Human Respiratory Epithelial Cell Lines to Respiratory Syncytial Virus Reflect Distinct Patterns of Infection Control (2018) (41)
- Long nucleotide insertions between the HN and L protein coding regions of human parainfluenza virus type 3 yield viruses with temperature-sensitive and attenuation phenotypes. (2000) (41)
- A paramyxovirus-vectored intranasal vaccine against Ebola virus is immunogenic in vector-immune animals. (2008) (40)
- Human parainfluenza virus type I (HPIV1) vaccine candidates designed by reverse genetics are attenuated and efficacious in African green monkeys. (2005) (40)
- Effects of Human Respiratory Syncytial Virus, Metapneumovirus, Parainfluenza Virus 3 and Influenza Virus on CD4+ T Cell Activation by Dendritic Cells (2010) (40)
- Complete Sequence of the RNA Genome of Pneumonia Virus of Mice (PVM) (2005) (40)
- Neonatal antibody responses are attenuated by interferon-γ produced by NK and T cells during RSV infection (2013) (40)
- Attenuating mutations in the P/C gene of human parainfluenza virus type 1 (HPIV1) vaccine candidates abrogate the inhibition of both induction and signaling of type I interferon (IFN) by wild-type HPIV1. (2006) (40)
- Complete genome sequence of avian paramyxovirus type 7 (strain Tennessee) and comparison with other paramyxoviruses. (2009) (39)
- Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children (2018) (38)
- Nucleotide sequences of the 1B and 1C nonstructural protein mRNAs of human respiratory syncytial virus. (1985) (38)
- Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children (2013) (38)
- Sequence Determination and Molecular Analysis of Two Strains of Bovine Parainfluenza Virus Type 3 that are Attenuated for Primates (2004) (38)
- Complete genome sequences of avian paramyxovirus serotype 6 prototype strain Hong Kong and a recent novel strain from Italy: evidence for the existence of subgroups within the serotype. (2010) (38)
- A live attenuated chimeric recombinant parainfluenza virus (PIV) encoding the internal proteins of PIV type 3 and the surface glycoproteins of PIV type 1 induces complete resistance to PIV1 challenge and partial resistance to PIV3 challenge. (1999) (38)
- Genetic stability of genome-scale deoptimized RNA virus vaccine candidates under selective pressure (2017) (37)
- Human Parainfluenza Virus Type 1 C Proteins Are Nonessential Proteins That Inhibit the Host Interferon and Apoptotic Responses and Are Required for Efficient Replication in Nonhuman Primates (2008) (37)
- The A and B subgroups of human respiratory syncytial virus: comparison of intergenic and gene-overlap sequences. (1988) (37)
- Determinants of the Host Range Restriction of Replication of Bovine Parainfluenza Virus Type 3 in Rhesus Monkeys Are Polygenic (2003) (36)
- Homooligomerization of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3 occurs before the acquisition of correct intramolecular disulfide bonds and mature immunoreactivity (1991) (36)
- Delivery of Cytokines by Recombinant Virus in Early Life Alters the Immune Response to Adult Lung Infection (2010) (36)
- A Y526Q Mutation in the Newcastle Disease Virus HN Protein Reduces Its Functional Activities and Attenuates Virus Replication and Pathogenicity (2009) (36)
- Avian paramyxovirus serotypes 2-9 (APMV-2-9) vary in the ability to induce protective immunity in chickens against challenge with virulent Newcastle disease virus (APMV-1). (2012) (36)
- Immunosuppression of the antibody response to respiratory syncytial virus (RSV) by pre-existing serum antibodies: partial prevention by topical infection of the respiratory tract with vaccinia virus-RSV recombinants. (1989) (36)
- Modified Newcastle disease virus vectors expressing the H5 hemagglutinin induce enhanced protection against highly pathogenic H5N1 avian influenza virus in chickens (2014) (35)
- Newcastle Disease Virus Expressing Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Induces Strong Mucosal and Serum Antibody Responses in Guinea Pigs (2011) (35)
- Effectiveness of enteric immunization in the development of secretory immunoglobulin A response and the outcome of infection with respiratory syncytial virus (1991) (35)
- The Cysteine-Rich Region and Secreted Form of the Attachment G Glycoprotein of Respiratory Syncytial Virus Enhance the Cytotoxic T-Lymphocyte Response despite Lacking Major Histocompatibility Complex Class I-Restricted Epitopes (2006) (34)
- Codon Substitution Mutations at Two Positions in the L Polymerase Protein of Human Parainfluenza Virus Type 1 Yield Viruses with a Spectrum of Attenuation In Vivo and Increased Phenotypic Stability In Vitro (2004) (34)
- Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans (2009) (34)
- Effect of passive antibody on the immune response of cotton rats to purified F and G glycoproteins of respiratory syncytial virus (RSV). (1991) (33)
- A Respiratory Syncytial Virus Replicon That Is Noncytotoxic and Capable of Long-Term Foreign Gene Expression (2011) (33)
- Live vaccines for human metapneumovirus designed by reverse genetics (2006) (33)
- A Chimeric Human-Bovine Parainfluenza Virus Type 3 Expressing Measles Virus Hemagglutinin Is Attenuated for Replication but Is Still Immunogenic in Rhesus Monkeys (2001) (33)
- Attenuation of the recombinant human parainfluenza virus type 3 cp45 candidate vaccine virus is augmented by importation of the respiratory syncytial virus cpts530 L polymerase mutation. (1999) (32)
- Synthesis and processing of Sindbis virus nonstructural proteins in vitro. (1982) (32)
- Rescue of a 7502-nucleotide (49.3% of full-length) synthetic analog of respiratory syncytial virus genomic RNA. (1993) (31)
- Role of Interferon in the Replication of Human Parainfluenza Virus Type 1 Wild Type and Mutant Viruses in Human Ciliated Airway Epithelium (2008) (31)
- Mutations in the Cytoplasmic Domain of the Newcastle Disease Virus Fusion Protein Confer Hyperfusogenic Phenotypes Modulating Viral Replication and Pathogenicity (2013) (31)
- Support plasmids and support proteins required for recovery of recombinant respiratory syncytial virus. (1999) (31)
- Codon stabilization analysis of the "248" temperature sensitive mutation for increased phenotypic stability of respiratory syncytial virus vaccine candidates. (2009) (31)
- Experimental infection of adults with recombinant wild-type human metapneumovirus. (2013) (30)
- Virally Delivered Cytokines Alter the Immune Response to Future Lung Infections (2007) (30)
- Respiratory Syncytial Virus Engineered To Express the Cystic Fibrosis Transmembrane Conductance Regulator Corrects the Bioelectric Phenotype of Human Cystic Fibrosis Airway Epithelium In Vitro (2010) (29)
- Complete Genome Sequence of a Novel Newcastle Disease Virus Strain Isolated from a Chicken in West Africa (2012) (29)
- Mapping and Characterization of the Primary and Anamnestic H-2d-Restricted Cytotoxic T-Lymphocyte Response in Mice against Human Metapneumovirus (2007) (29)
- A Comprehensive Proteomic View of Responses of A549 Type II Alveolar Epithelial Cells to Human Respiratory Syncytial Virus Infection* (2014) (29)
- Problems of classification in the family Paramyxoviridae (2018) (29)
- Respiratory Syncytial Virus Can Tolerate an Intergenic Sequence of at Least 160 Nucleotides with Little Effect on Transcription or Replication In Vitro and In Vivo (2000) (29)
- Live viral vaccines for respiratory and enteric tract diseases. (1988) (29)
- Intracellular amplification and expression of a synthetic analog of rotavirus genomic RNA bearing a foreign marker gene: mapping cis-acting nucleotides in the 3'-noncoding region. (1992) (28)
- Complete genome sequence of avian paramyxovirus-3 strain Wisconsin: evidence for the existence of subgroups within the serotype. (2010) (28)
- Effect of Coexpression of Interleukin-2 by Recombinant Respiratory Syncytial Virus on Virus Replication, Immunogenicity, and Production of Other Cytokines (2000) (28)
- Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector (2016) (28)
- Impairment of the CD8+ T cell response in lungs following infection with human respiratory syncytial virus is specific to the anatomical site rather than the virus, antigen, or route of infection (2008) (27)
- Coordinate Deletion of N-Glycans from the Heptad Repeats of the Fusion F Protein of Newcastle Disease Virus Yields a Hyperfusogenic Virus with Increased Replication, Virulence, and Immunogenicity (2011) (27)
- Deletion of Nonstructural Proteins NS1 and NS2 from Pneumonia Virus of Mice Attenuates Viral Replication and Reduces Pulmonary Cytokine Expression and Disease (2008) (27)
- Mutations in the Fusion Protein Cleavage Site of Avian Paramyxovirus Serotype 2 Increase Cleavability and Syncytium Formation but Do Not Increase Viral Virulence in Chickens (2011) (27)
- Expression of Interleukin-4 by Recombinant Respiratory Syncytial Virus Is Associated with Accelerated Inflammation and a Nonfunctional Cytotoxic T-Lymphocyte Response following Primary Infection but Not following Challenge with Wild-Type Virus (2005) (27)
- Introducing point and deletion mutations into the P/C gene of human parainfluenza virus type 1 (HPIV1) by reverse genetics generates attenuated and efficacious vaccine candidates. (2006) (27)
- The C Proteins of Human Parainfluenza Virus Type 1 Block IFN Signaling by Binding and Retaining Stat1 in Perinuclear Aggregates at the Late Endosome (2012) (27)
- Both Nonstructural Proteins NS1 and NS2 of Pneumonia Virus of Mice are Inhibitors of the Interferon Type I and Type III Responses In Vivo (2011) (26)
- Chimeric Bovine/Human Parainfluenza Virus Type 3 Expressing Respiratory Syncytial Virus (RSV) F Glycoprotein: Effect of Insert Position on Expression, Replication, Immunogenicity, Stability, and Protection against RSV Infection (2014) (26)
- Identification of a Novel Virulence Factor in Recombinant Pneumonia Virus of Mice (2007) (26)
- Live-attenuated intranasal parainfluenza virus type 2 vaccine candidates developed by reverse genetics containing L polymerase protein mutations imported from heterologous paramyxoviruses. (2005) (26)
- Human Metapneumovirus SH and G Glycoproteins Inhibit Macropinocytosis-Mediated Entry into Human Dendritic Cells and Reduce CD4+ T Cell Activation (2014) (26)
- Improved Prefusion Stability, Optimized Codon Usage, and Augmented Virion Packaging Enhance the Immunogenicity of Respiratory Syncytial Virus Fusion Protein in a Vectored-Vaccine Candidate (2017) (26)
- Evaluation of a Live Attenuated Human Metapneumovirus Vaccine in Adults and Children (2017) (26)
- Safety and Immunogenicity of the Respiratory Syncytial Virus Vaccine RSV/ΔNS2/Δ1313/I1314L in RSV-Seronegative Children (2019) (26)
- The alpha-1 subunit of the Na+,K+-ATPase (ATP1A1) is required for macropinocytic entry of respiratory syncytial virus (RSV) in human respiratory epithelial cells (2019) (25)
- Expression of the G glycoprotein gene of human respiratory syncytial virus in Salmonella typhimurium. (1993) (25)
- Experimental infection of hamsters with avian paramyxovirus serotypes 1 to 9 (2011) (25)
- Complete genome sequences of avian paramyxovirus serotype 2 (APMV-2) strains Bangor, England and Kenya: evidence for the existence of subgroups within serotype 2. (2010) (25)
- Attenuation of Human Respiratory Viruses by Synonymous Genome Recoding (2019) (25)
- Expression of the F glycoprotein gene from human respiratory syncytial virus in Escherichia coli: mapping of a fusion inhibiting epitope. (1991) (25)
- Complete sequence of the major nucleocapsid protein gene of human parainfluenza type 3 virus: comparison with other negative strand viruses. (1986) (25)
- Sequence analysis of the matrix protein gene of human parainfluenza virus type 3: extensive sequence homology among paramyxoviruses. (1987) (24)
- Complete Genome Sequence of a Highly Virulent Newcastle Disease Virus Currently Circulating in Mexico (2013) (24)
- Attenuation and efficacy of human parainfluenza virus type 1 (HPIV1) vaccine candidates containing stabilized mutations in the P/C and L genes (2007) (24)
- Deletion and substitution analysis defines regions and residues within the phosphoprotein of bovine respiratory syncytial virus that affect transcription, RNA replication, and interaction with the nucleoprotein. (2001) (24)
- Mutational analysis of the bovine respiratory syncytial virus nucleocapsid protein using a minigenome system: mutations that affect encapsidation, RNA synthesis, and interaction with the phosphoprotein. (2000) (23)
- Respiratory syncytial virus infection induces a subset of types I and III interferons in human dendritic cells. (2017) (23)
- Sequence comparison of the phosphoprotein mRNAs of antigenic subgroups A and B of human respiratory syncytial virus identifies a highly divergent domain in the predicted protein. (1990) (23)
- Cytotoxic T cell activity against the 22-kDa protein of human respiratory syncytial virus (RSV) is associated with a significant reduction in pulmonary RSV replication. (1991) (23)
- Human parainfluenza virus serotypes differ in their kinetics of replication and cytokine secretion in human tracheobronchial airway epithelium. (2012) (23)
- A host-restricted viral vector for antigen-specific immunization against Lyme disease pathogen (2011) (22)
- The Major Attenuating Mutations of the Respiratory Syncytial Virus Vaccine Candidate cpts530/1009 Specify Temperature-Sensitive Defects in Transcription and Replication and a Non-Temperature-Sensitive Alteration in mRNA Termination (1999) (22)
- What Are the Risks—Hypothetical and Observed—of Recombination Involving Live Vaccines and Vaccine Vectors Based on Nonsegmented Negative-Strain RNA Viruses? (2008) (22)
- Live respiratory syncytial virus attenuated by M2-2 deletion and stabilized temperature sensitivity mutation 1030s is a promising vaccine candidate in children. (2019) (21)
- Mutation of the F-Protein Cleavage Site of Avian Paramyxovirus Type 7 Results in Furin Cleavage, Fusion Promotion, and Increased Replication In Vitro but Not Increased Replication, Tissue Tropism, or Virulence in Chickens (2012) (21)
- Sequence analysis of a functional polymerase (L) gene of bovine respiratory syncytial virus: determination of minimal trans-acting requirements for RNA replication. (1998) (21)
- Influence of a Single Viral Epitope on T Cell Response and Disease After Infection of Mice with Respiratory Syncytial Virus1 (2007) (21)
- Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector (2013) (21)
- Experimental avian paramyxovirus serotype-3 infection in chickens and turkeys (2010) (20)
- Possibility and Challenges of Conversion of Current Virus Species Names to Linnaean Binomials. (2016) (19)
- Effects of Altering the Transcription Termination Signals of Respiratory Syncytial Virus on Viral Gene Expression and Growth In Vitro and In Vivo (2004) (19)
- Detection of respiratory syncytial virus (RSV) infected cells by in situ hybridization in the lungs of cotton rats immunized with formalin-inactivated virus or purified RSV F and G glycoprotein subunit vaccine and challenged with RSV. (1990) (19)
- Effects of Alterations to the CX3C Motif and Secreted Form of Human Respiratory Syncytial Virus (RSV) G Protein on Immune Responses to a Parainfluenza Virus Vector Expressing the RSV G Protein (2019) (19)
- More antibody with less antigen: Can immunogenicity of attenuated live virus vaccines be improved? (2002) (18)
- Mutation of the elongin C binding domain of human respiratory syncytial virus non-structural protein 1 (NS1) results in degradation of NS1 and attenuation of the virus (2011) (18)
- Evaluation of a Live-Attenuated Human Parainfluenza Type 1 Vaccine in Adults and Children. (2015) (18)
- Reevaluation of the Virulence of Prototypic Strain 15 of Pneumonia Virus of Mice (2004) (18)
- Human parainfluenza virus type 2 V protein inhibits interferon production and signaling and is required for replication in non-human primates (2009) (18)
- Recombinant human parainfluenza virus type 2 vaccine candidates containing a 3' genomic promoter mutation and L polymerase mutations are attenuated and protective in non-human primates. (2007) (18)
- Detection and quantitation of human respiratory syncytial virus (RSV) using minigenome cDNA and a Sindbis virus replicon: a prototype assay for negative-strand RNA viruses. (1998) (17)
- Identification of Human Parainfluenza Virus Type 2 (HPIV-2) V Protein Amino Acid Residues That Reduce Binding of V to MDA5 and Attenuate HPIV-2 Replication in Nonhuman Primates (2011) (17)
- Acquisition of the ts phenotype by a chemically mutagenized cold-passaged human respiratory syncytial virus vaccine candidate results from the acquisition of a single mutation in the polymerase (L) gene (2004) (17)
- O glycosylation of glycoprotein G of human respiratory syncytial virus is specified within the divergent ectodomain (1990) (16)
- Experimental Infection of Mice with Avian Paramyxovirus Serotypes 1 to 9 (2011) (16)
- Pathogenesis of Two Strains of Avian Paramyxovirus Serotype 2, Yucaipa and Bangor, in Chickens and Turkeys (2010) (16)
- Human parainfluenza virus type 3 expressing the respiratory syncytial virus pre-fusion F protein modified for virion packaging yields protective intranasal vaccine candidates (2020) (15)
- Mutations in the Fusion Protein Cleavage Site of Avian Paramyxovirus Serotype 4 Confer Increased Replication and Syncytium Formation In Vitro but Not Increased Replication and Pathogenicity in Chickens and Ducks (2013) (15)
- Live-Attenuated Respiratory Syncytial Virus Vaccine With Deletion of RNA Synthesis Regulatory Protein M2-2 and Cold Passage Mutations Is Overattenuated (2019) (14)
- An improved method for the recovery of recombinant paramyxovirus vaccine candidates suitable for use in human clinical trials. (2007) (14)
- Attenuated Human Parainfluenza Virus Type 1 Expressing the Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein from an Added Gene: Effects of Prefusion Stabilization and Packaging of RSV F (2017) (14)
- Live-attenuated respiratory syncytial virus vaccine with M2-2 deletion and with SH non-coding region is highly immunogenic in children. (2020) (14)
- Live-attenuated Vaccines Prevent Respiratory Syncytial Virus-associated Illness in Young Children. (2020) (14)
- In silico identification of a putative new paramyxovirus related to the Henipavirus genus. (2004) (14)
- The cDNA-derived Investigational Human Parainfluenza Virus Type 3 Vaccine rcp45 Is Well Tolerated, Infectious, and Immunogenic in Infants and Young Children (2011) (13)
- Vaccines against Human Respiratory Syncytial Virus (2006) (13)
- Human Respiratory Syncytial Virus Genome and Gene Products (1986) (13)
- Attenuated Human Parainfluenza Virus Type 1 (HPIV1) Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus (RSV) as a Bivalent HPIV1/RSV Vaccine (2015) (13)
- Ebola vaccine–induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effects (2021) (13)
- Construction of a live-attenuated bivalent vaccine virus against human parainfluenza virus (PIV) types 1 and 2 using a recombinant PIV3 backbone. (2001) (12)
- Attenuated Human Parainfluenza Virus Type 1 Expressing Ebola Virus Glycoprotein GP Administered Intranasally Is Immunogenic in African Green Monkeys (2017) (12)
- The C Proteins of Human Parainfluenza Virus Type 1 (HPIV1) Control the Transcription of a Broad Array of Cellular Genes That Would Otherwise Respond to HPIV1 Infection (2008) (12)
- Alix Serves as an Adaptor That Allows Human Parainfluenza Virus Type 1 to Interact with the Host Cell ESCRT System (2013) (12)
- Current status of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccine development: memorandum from a joint WHO/NIAID meeting. (1997) (12)
- Attenuation of live respiratory syncytial virus vaccines is associated with reductions in levels of nasal cytokines. (2013) (12)
- Evaluation of the genetic diversity of avian paramyxovirus type 4. (2013) (11)
- Evaluation of Pneumonia Virus of Mice as a Possible Human Pathogen (2012) (11)
- α-Fetoprotein gene delivery to the nasal epithelium of nonhuman primates by human parainfluenza viral vectors. (2010) (11)
- Rescue of Bovine Respiratory Syncytial Virus from Cloned cDNA: Entire Genome Sequence of BRSV Strain A51908 (2004) (11)
- A novel host factor for human respiratory syncytial virus (2017) (11)
- Recombinant human parainfluenza virus type 2 with mutations in V that permit cellular interferon signaling are not attenuated in non-human primates. (2010) (11)
- Intracellular processing and transport of NH2-terminally truncated forms of a hemagglutinin-neuraminidase type II glycoprotein (1990) (10)
- Multicolor Stimulated Emission Depletion (STED) Microscopy to Generate High-resolution Images of Respiratory Syncytial Virus Particles and Infected Cells. (2017) (10)
- Evaluation of the Replication, Pathogenicity, and Immunogenicity of Avian Paramyxovirus (APMV) Serotypes 2, 3, 4, 5, 7, and 9 in Rhesus Macaques (2013) (10)
- Optimization of the Codon Pair Usage of Human Respiratory Syncytial Virus Paradoxically Resulted in Reduced Viral Replication In Vivo and Reduced Immunogenicity (2019) (10)
- A TRANSCRIPTIONAL MAP OF VESICULAR STOMATITIS VIRUS (1976) (9)
- A novel human parainfluenza virus type 1 (HPIV1) with separated P and C genes is useful for generating C gene mutants for evaluation as live-attenuated virus vaccine candidates. (2010) (9)
- LaSota fusion (F) cleavage motif-mediated fusion activity is affected by other regions of the F protein from different genotype Newcastle disease virus in a chimeric virus: implication for virulence attenuation. (2016) (9)
- Role of C596 in the C-terminal extension of the haemagglutinin-neuraminidase protein in replication and pathogenicity of a highly virulent Indonesian strain of Newcastle disease virus. (2014) (9)
- Interprotomer disulfide-stabilized variants of the human metapneumovirus fusion glycoprotein induce high titer-neutralizing responses (2021) (8)
- Vaccines Against Respiratory Syncytial Virus and Parainfluenza Viruses (2016) (8)
- Complete Genome Sequence of an Avian Paramyxovirus Type 4 from North America Reveals a Shorter Genome and New Genotype (2013) (8)
- Identification of Simian Agent 10 as Human Parainfluenza Virus Type 3 Suggests Transmission of a Human Virus to an African Monkey (2010) (7)
- Antibody Repertoires to the Same Ebola Vaccine Antigen Are Differentially Affected by Vaccine Vectors (2018) (7)
- Effects of Naturally Occurring Six- and Twelve-Nucleotide Inserts on Newcastle Disease Virus Replication and Pathogenesis (2014) (7)
- Primary pulmonary murine cytotoxic T lymphocyte specificity in respiratory syncytial virus pneumonia. (1990) (6)
- The NS2 Protein of Human Respiratory Syncytial Virus Suppresses the Cytotoxic T-Cell Response as a Consequence of Suppressing the Type I Interferon Response (2006) (5)
- Rescue of a bovine respiratory syncytial virus genomic RNA analog by bovine, human and ovine respiratory syncytial viruses confirms the “functional integrity” and “cross-recognition” of BRSV cis-acting elements by HRSV and ORSV (2014) (5)
- IDENTIFICATION OF A NEW ENVELOPE-ASSOCIATED PROTEIN OF HUMAN RESPIRATORY SYNCYTIAL VIRUS1 (1984) (5)
- A Parainfluenza Virus Vector Expressing the Respiratory Syncytial Virus (RSV) Prefusion F Protein Is More Effective than RSV for Boosting a Primary Immunization with RSV (2020) (4)
- Murine Pneumonia Virus Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus from an Added Gene Is Highly Attenuated and Immunogenic in Rhesus Macaques (2018) (4)
- Filovirus vaccines: what challenges are left? (2010) (4)
- Lack of Activation Marker Induction and Chemokine Receptor Switch in Human Neonatal Myeloid Dendritic Cells in Response to Human Respiratory Syncytial Virus (2019) (4)
- Proteoform-Specific Insights into Cellular Proteome Regulation* (2016) (3)
- Both Nonstructural Proteins 1 and 2 of Pneumonia Virus of Mice are Inhibitors of the Interferon Type I and III Response In Vivo (2011) (3)
- Rescue of codon-pair deoptimized respiratory syncytial virus by the emergence of genomes with very large internal deletions that complemented replication (2021) (3)
- RESPIRATORY SYNCYTIAL VIRUS – HUMAN (PARAMYXOVIRIDAE) (1999) (3)
- The Aberrant Gene-End Transcription Signal of the Matrix M Gene of Human Parainfluenza Virus Type 3 Downregulates Fusion F Protein Expression and the F-Specific Antibody Response In Vivo (2015) (3)
- Successful Topical Respiratory Tract Immunization of Primates (2007) (2)
- Role of C 596 in the C-terminal extension of the haemagglutinin – neuraminidase protein in replication and pathogenicity of a highly virulent Indonesian strain of Newcastle disease virus (2014) (2)
- Gene products and genome organization of human respiratory syncytial virus (1985) (2)
- Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccines RSV/ΔNS2/Δ1313/I1314L and RSV/276 in RSV Seronegative Children. (2022) (2)
- Retraction for Khattar et al., “Newcastle Disease Virus Expressing Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Induces Strong Mucosal and Serum Antibody Responses in Guinea Pigs” (2020) (2)
- A critical role for dendritic cells in immunosuppression caused by the respiratory syncytial virus (RSV) (2005) (1)
- Safety and Immunogenicity of the Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine Respiratory Syncytial Virus (RSV) Cps2 in RSV-Seronegative Infants and Children (2015) (1)
- High infectivity of recombinant live-attenuated respiratory syncytial virus vaccine (RSV LID ΔM2-2) in infants and children (2015) (1)
- cDNA CLONING, MAPPING AND TRANSLATION OF TEN RESPIRATORY SYNCYTIAL VIRUS mRNAs1 (1984) (1)
- Retraction for Kumar et al., “Evaluation of the Newcastle Disease Virus F and HN Proteins in Protective Immunity by Using a Recombinant Avian Paramyxovirus Type 3 Vector in Chickens” (2020) (1)
- Respiratory Syncytial Virus-Induced Host IFN Signaling Differs Between A549 and BEAS-2B Epithelial Cell Lines (2015) (1)
- Reversion mutations in phosphoprotein P of a codon-pair-deoptimized human respiratory syncytial virus confer increased transcription, immunogenicity, and genetic stability without loss of attenuation (2021) (1)
- HOW MANY FORMS OF THE NEWCASTLE DISEASE VIRUS P PROTEIN ARE THERE?1 (1984) (1)
- Advances in the development of vaccines against Marburg and Ebola viruses. (2007) (1)
- Identification of a phosphorylated non-structural form of the P protein of Newcastle disease virus and analysis of P multimers. (1984) (1)
- Syncytial Virus Infection Respiratory Mucin Response to Pathogenic Airway Protein and Neutrophils Mediate the The Respiratory Syncytial Virus Fusion (2014) (0)
- Retraction notice to "Modified Newcastle disease virus vectors expressing the H5 hemagglutinin induce enhanced protection against highly pathogenic H5N1 avian influenza virus in chickens" [Vaccine 32(35) (2014) 4428-4435]. (2021) (0)
- Expression of human respiratory syncytial virus glycoprotein genes from recombinant vaccinia virus vectors (1985) (0)
- MINIREVIEW Nonsegmented Negative-Strand Viruses as Vaccine Vectors (2006) (0)
- Human-bovine attenuated chimeric parainfluenza virus (PIV). (2000) (0)
- Correction: Generation by Reverse Genetics of an Effective, Stable, Live-Attenuated Newcastle Disease Virus Vaccine Based on a Currently Circulating, Highly Virulent Indonesian Strain (2022) (0)
- O Glycosylation ofGlycoprotein G ofHumanRespiratory Syncytial VirusIsSpecified within theDivergent Ectodomain (1990) (0)
- Exploring host range restriction to make improved vaccine : HRSV/BRSV chimeric viruses (2002) (0)
- Evaluation of a live-attenuated human parainfluenza virus type 2 vaccine in adults and children. (2023) (0)
- EpitopeImmunopathology Caused by a Dominant Cell Epitope Protect against T + Responses against a Subdominant CD8 (2010) (0)
- Efficacy of a Current Vaccine Viruses Circulating in West Africa and Characterization of Newcastle Disease Phylogenetic and Pathotypic (2014) (0)
- Detection de virus a arn negatif (1999) (0)
- Taxonomy of the order Mononegavirales: update 2017 (2017) (0)
- Identification of a Novel Virulence Factor in Recombinant Pneumonia Virus of Mice (cid:1) (2007) (0)
- Innate IFNs and pro-inflammatory cytokines in local control of Respiratory Syncytial Virus infection of respiratory epithelial cells. (2016) (0)
- Taxonomy of the order Mononegavirales: update 2018 (2018) (0)
- LSC 2013 abstract - Mast cells support rhinovirus but not respiratory syncytial virus replication and contribute to the pro-inflammatory response to rhinovirus (2013) (0)
- Homooligomerization oftheHemagglutinin-Neuraminidase Glycoprotein ofHumanParainfluenza Virus Type3Occurs before theAcquisition ofCorrect Intramolecular Disulfide BondsandMatureImmunoreactivity (1991) (0)
- Transcription andTranslation ofNewcastle Disease Virus (1978) (0)
- Correction for Samal et al., “Mutations in the Cytoplasmic Domain of the Newcastle Disease Virus Fusion Protein Confer Hyperfusogenic Phenotypes Modulating Viral Replication and Pathogenicity” (2020) (0)
- Taxonomy of the order Mononegavirales: update 2016 (2016) (0)
- Replicon de virus a arn de polarite negative (2004) (0)
- Correction: Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector (2014) (0)
- T cell response to respiratory syncytial virus (RSV) (2004) (0)
- Pathogenesis of Two Strains of Avian Paramyxovirus Serotype 2, Yucaipa and Bangor, in Chickens and Turkeys (2010) (0)
- An attenuated innate immune response to a clinical strain of respiratory syncytial virus (RSV) in human monocyte derived dendritic cells (MDDC) (37.43) (2010) (0)
- Recombinant parainfluenza virus vaccine, the suppression by deletion or a non-essential gene is attenuated (2000) (0)
- SHORT COMMUNICATION Nucleotide Sequence Analysis of the Respiratory Syncytial Virus Subgroup A Cold-Passaged (cp) Temperature Sensitive (ts) cpts-248/404 Live Attenuated Virus Vaccine Candidate 1 (1996) (0)
- Functional Characterization of A Cis-Acting Temperature Sensitive Mutation From A Respiratory Syncytial Virus Vaccine Candidate (2013) (0)
- RescueofSynthetic Analogs ofGenomicRNA and Replicative-Inte rmediate RNA ofHuman Parainfluenza VirusType3 (1993) (0)
- 2777. Live-Attenuated Vaccine Against RSV Generates Robust Cellular and Humoral Immune Responses (2019) (0)
- RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING RSV G AND ITS USE (2018) (0)
- Antigenic variation in the hn protein of human parainfluenza type 3 virus (1985) (0)
- Identification of Human Parainfluenza Virus Type 2 (HPIV-2) V Protein Amino Acid Residues That Reduce Binding of V to MDA5 and Attenuate HPIV-2 Replication in Nonhuman Primates (cid:1) (2011) (0)
- 687. Parainfluenza virus-mediated delivery of CFTR to ciliated cells corrects the CF bioelectrical chloride secretory defect and restores the regulation of airway surface liquid depth and mucus transport to cystic fibrosis airway epithelium (2004) (0)
- Sequence Analysis of the Washington/1964 strain of Human Parainfluenza Virus Type 1 (HPIV1) and Recovery and Characterization of Wild Type Recombinant HPIV1 Produced by Reverse Genetics (2005) (0)
- Cholesterol-Rich Microdomains as Docking Platforms for Respiratory Syncytial Virus in Normal Human Bronchial Epithelial Cells (2012) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Peter L. Collins?
Peter L. Collins is affiliated with the following schools:
